We have received a beta-cell replacement Innovative grant from the Juvenile Diabetes Research Foundation - "Substrate Activated Prodrug Strategies for the Protection of Transplanted Islets and Beta Cells ". Way to go team!
JDRF Grant awarded to Kane Group
Commentaires